TRDA - Entrada Therapeutics GAAP EPS of -$0.80 misses by $0.05 November, 07 2022 08:39 AM Entrada Therapeutics Inc. Entrada Therapeutics press release ( NASDAQ: TRDA ): Q3 GAAP EPS of -$0.80 misses by $0.05 . Cash and cash equivalents of $53.31M For further details see: Entrada Therapeutics GAAP EPS of -$0.80 misses by $0.05